Health care utilization by long-term survivors of blood or marrow transplantation-A Bone Marrow Transplant Survivor Study report.
BMT
allogeneic or autologous transplant
blood or marrow transplantation
healthcare utilization
long-term survivors
survivors
Journal
Cancer
ISSN: 1097-0142
Titre abrégé: Cancer
Pays: United States
ID NLM: 0374236
Informations de publication
Date de publication:
25 Oct 2023
25 Oct 2023
Historique:
revised:
05
09
2023
received:
14
06
2023
accepted:
03
10
2023
medline:
26
10
2023
pubmed:
26
10
2023
entrez:
26
10
2023
Statut:
aheadofprint
Résumé
Blood or marrow transplantation (BMT) survivors carry a high burden of morbidity, yet health care utilization by this vulnerable population remains understudied. Patterns and predictors of various domains of health care utilization in long-term BMT survivors were evaluated. Study participants were drawn from the Bone Marrow Transplant Survivor Study (BMTSS). Patients transplanted between 1974 and 2014 at one of three transplant centers who had survived ≥2 years after BMT and were aged ≥18 years at the time of the study were included. A BMTSS survey served as the source of data for health care utilization, sociodemographics, and chronic health conditions. Domains of health care utilization in the 2 years preceding study participation included routine checkups, BMT-related visits, transplant/cancer center visits, emergency room (ER) visits, hospitalizations, and high health care utilization (≥7 physician visits during the 2 years before the study). Clinical characteristics and therapeutic exposures were abstracted from medical records. In this cohort of 3342 BMT survivors (52% allogeneic), the prevalence of health care utilization declined over time since BMT for both allogeneic and autologous BMT survivors, such that among those who had survived ≥20 years, only 49%-53% had undergone routine checkups, 37%-38% reported BMT-related visits, and 28%-29% reported transplant/cancer center visits. The presence of severe/life-threatening conditions and chronic graft-vs-host disease increased the odds of health care utilization across all domains. Lower education, lack of insurance, and Hispanic ethnicity were associated with a lower prevalence of routine checkups and/or transplant/cancer center visits. Lower income increased the odds of ER visits but reduced the odds of hospitalizations or high health care utilization. This study identified vulnerable populations of long-term BMT survivors who would benefit from specialized risk-based anticipatory care to reduce high health care utilization, ER visits, and hospitalizations.
Sections du résumé
BACKGROUND
BACKGROUND
Blood or marrow transplantation (BMT) survivors carry a high burden of morbidity, yet health care utilization by this vulnerable population remains understudied. Patterns and predictors of various domains of health care utilization in long-term BMT survivors were evaluated.
METHODS
METHODS
Study participants were drawn from the Bone Marrow Transplant Survivor Study (BMTSS). Patients transplanted between 1974 and 2014 at one of three transplant centers who had survived ≥2 years after BMT and were aged ≥18 years at the time of the study were included. A BMTSS survey served as the source of data for health care utilization, sociodemographics, and chronic health conditions. Domains of health care utilization in the 2 years preceding study participation included routine checkups, BMT-related visits, transplant/cancer center visits, emergency room (ER) visits, hospitalizations, and high health care utilization (≥7 physician visits during the 2 years before the study). Clinical characteristics and therapeutic exposures were abstracted from medical records.
RESULTS
RESULTS
In this cohort of 3342 BMT survivors (52% allogeneic), the prevalence of health care utilization declined over time since BMT for both allogeneic and autologous BMT survivors, such that among those who had survived ≥20 years, only 49%-53% had undergone routine checkups, 37%-38% reported BMT-related visits, and 28%-29% reported transplant/cancer center visits. The presence of severe/life-threatening conditions and chronic graft-vs-host disease increased the odds of health care utilization across all domains. Lower education, lack of insurance, and Hispanic ethnicity were associated with a lower prevalence of routine checkups and/or transplant/cancer center visits. Lower income increased the odds of ER visits but reduced the odds of hospitalizations or high health care utilization.
CONCLUSIONS
CONCLUSIONS
This study identified vulnerable populations of long-term BMT survivors who would benefit from specialized risk-based anticipatory care to reduce high health care utilization, ER visits, and hospitalizations.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCI NIH HHS
ID : R01 CA078938
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA213140
Pays : United States
Informations de copyright
© 2023 American Cancer Society.
Références
Bhatia S, Dai C, Landier W, et al. Trends in late mortality and life expectancy after allogeneic blood or marrow transplantation over 4 decades: a Blood or Marrow Transplant Survivor Study report. JAMA Oncol. 2021;7(11):1626-1634. doi:10.1001/jamaoncol.2021.3676
Bhatia S, Dai C, Landier W, et al. Trends in late mortality and life expectancy after autologous blood or marrow transplantation over three decades: a BMTSS report. J Clin Oncol. 2022;40(18):1991-2003. doi:10.1200/JCO.21.02372
Sun CL, Francisco L, Kawashima T, et al. Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Blood. 2010;116(17):3129-3139. doi:10.1182/blood-2009-06-229369
Sun CL, Kersey JH, Francisco L, et al. Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Biol Blood Marrow Transplant. 2013;19(7):1073-1080. doi:10.1016/j.bbmt.2013.04.002
Armenian SH, Sun CL, Francisco L, et al. Late congestive heart failure after hematopoietic cell transplantation. J Clin Oncol. 2008;26(34):5537-5543. doi:10.1200/JCO.2008.17.7428
Armenian SH, Sun CL, Kawashima T, et al. Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS). Blood. 2011;118(5):1413-1420. doi:10.1182/blood-2011-01-331835
Armenian SH, Sun CL, Vase T, et al. Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease. Blood. 2012;120(23):4505-4512. doi:10.1182/blood-2012-06-437178
Baker KS, Armenian S, Bhatia S. Long-term consequences of hematopoietic stem-cell transplantation: current state of the science. Biol Blood Marrow Transplant. 2010;16(1):S90-S96. doi:10.1016/j.bbmt.2009.09.017
Baker KS, Gurney JG, Ness KK, et al. Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study. Blood. 2004;104(6):1898-1906. doi:10.1182/blood-2004-03-1010
Baker KS, Ness KK, Steinberger J, et al. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplantation Survivor Study. Blood. 2007;109(4):1765-1772. doi:10.1182/blood-2006-05-022335
Baker KS, Ness KK, Weisdorf D, et al. Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Leukemia. 2010;24(12):2039-2047. doi:10.1038/leu.2010.210
Majhail NS, Ness KK, Burns LJ, et al. Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Biol Blood Marrow Transplant. 2007;13(10):1153-1159. doi:10.1016/j.bbmt.2007.06.003
Hashmi S, Carpenter P, Khera N, Tichelli A, Savani BN. Lost in transition: the essential need for long-term follow-up clinic for blood and marrow transplantation survivors. Biol Blood Marrow Transplant. 2015;21(2):225-232. doi:10.1016/j.bbmt.2014.06.035
Shankar S, Carter A, Sun C-L, et al. Health care utilization by adult long-term survivors of hematopoietic cell transplant: report from the Bone Marrow Transplant Survivor Study. Cancer Epidemiol Biomarkers Prev. 2007;16(4):834-839. doi:10.1158/1055-9965.epi-06-0714
Nathan PC, Ford JS, Henderson TO, et al. Health behaviors, medical care, and interventions to promote healthy living in the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009;27(14):2363-2373. doi:10.1200/JCO.2008.21.1441
Nathan PC, Greenberg ML, Ness KK, et al. Medical care in long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2008;26(27):4401-4409. doi:10.1200/JCO.2008.16.9607
Armenian SH, Sun CL, Shannon T, et al. Incidence and predictors of congestive heart failure following autologous hematopoietic cell transplantation. Blood. 2011;118(23):6023-6029. doi:10.1182/blood-2011-06-358226
McDonald A, Dai C, Meng Q, et al. Malignant neoplasms of the gastrointestinal tract after blood or marrow transplant. JAMA Oncol. 2023;9(3):376. doi:10.1001/jamaoncol.2022.6569
McDonald AM, Chen Y, Wu J, et al. Total body irradiation and risk of breast cancer after blood or marrow transplantation: a Blood or Marrow Transplantation Survivor Study report. J Clin Oncol. 2020;38(25):2872-2882. doi:10.1200/JCO.20.00231
Fraser CJ, Bhatia S, Ness K, et al. Impact of chronic graft vs. host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study. Blood. 2006;108(8):2867-2873. doi:10.1182/blood-2006-02-003954
Wolfson JA, Bhatia S, Hageman L, et al. Neighborhood disadvantage, health status, and health care utilization after blood or marrow transplant: BMTSS report. Blood Adv. 2023;7(3):293-301. doi:10.1182/bloodadvances.2022007548
Singh GK, Jemal A. Socioeconomic and racial/ethnic disparities in cancer mortality, incidence, and survival in the United States, 1950-2014: over six decades of changing patterns and widening inequalities. J Environ Public Health. 2017;2017:2819372. doi:10.1155/2017/2819372
Singh GK, Williams SD, Siahpush M, Mulhollen A. Socioeconomic, rural-urban, and racial inequalities in US cancer mortality: part I-all cancers and lung cancer and part II-colorectal, prostate, breast, and cervical cancers. J Cancer Epidemiol. 2011;2011:107497. doi:10.1155/2011/107497
Peersman W, Pasteels I, Cambier D, De Maeseneer J, Willems S. Validity of self-reported utilization of physician services: a population study. Eur J Public Health. 2013;24(1):91-97. doi:10.1093/eurpub/ckt079
Majhail NS, Rizzo JD, Lee SJ, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Hematol Oncol Stem Cell Ther. 2012;5(1):1-30. doi:10.5144/1658-3876.2012.1